ETFs Holding AEZS

For investors looking for the best ETF with AEZS, use this page to see which ETFs hold AEZS, COSCIENS Biopharma Inc, and how much exposure each fund has to the stock. For investors comparing ETF holdings, this is one of the fastest ways to see where COSCIENS Biopharma Inc shows up across broad market funds, growth versus value funds, sector ETFs, and other strategies.

The data below shows the number of ETFs holding AEZS, the total market value of those holdings, and the weight COSCIENS Biopharma Inc carries inside individual funds. For quick use, jump straight to the holdings table. For broader ETF research, use the ETF Finder and related tools across ETF Channel.

AEZS Description — COSCIENS Biopharma Inc

Aeterna Zentaris is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Co.'s primary product, macimorelin, is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency. Macimorelin is marketed in the U.S. under the tradename Macrilen™ through a license agreement with Novo Nordisk.
Company Name:  COSCIENS Biopharma Inc
Website:  www.zentaris.com
Sector:  Drugs & Pharmaceuticals

Browse ETF screens, holdings-related research, dividend and yield pages, analyst screens, and related market idea pages from across the channel network. These links are grouped by topic to make the list easier to scan.

Dividend, Yield, and Income Research

Dividend and income-oriented screens that are relevant to ETF investors comparing holdings, yield exposure, and stock selection ideas.

Energy, Metals, and Canada Research

Cross-network sector research pages that may be useful for investors following ETF exposure to energy, metals, and Canadian markets.